Antonio Palumbo, MD, from the University of Turin, Turin, Italy provides treatment advice for smouldering myeloma. The key message, according to Dr Palumbo, is that today, smouldering myeloma is defined by the presence of 3g/dL of M-component and at least 10% bone marrow plasma cells. Further, Dr Palumbo discusses ultra high-risk smouldering myeloma and high-risk smouldering myeloma.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content